Reference
Rossi V, et al. How safe is it to administer dual anti-HER2 block with pertuzumab and trastuzumab on a patient with life-threatening liver breast cancer metastasis?. Breast Cancer Management 9: No. 3, Sep 2020. Available from: URL: http://doi.org/10.2217/bmt-2020-0019
Rights and permissions
About this article
Cite this article
Paclitaxel. Reactions Weekly 1832, 237 (2020). https://doi.org/10.1007/s40278-020-86770-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-86770-8